Daniel Schneider
Amministratore Delegato presso PHOTOCURE ASA
Patrimonio netto: 497 808 $ in data 30/04/2024
Posizioni attive di Daniel Schneider
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| PHOTOCURE ASA | Amministratore Delegato | 01/11/2018 | - |
| Presidente | 01/11/2018 | - |
Storia della carriera di Daniel Schneider
Precedenti posizioni note di Daniel Schneider
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| ABLYNX | Amministratore Delegato | - | - |
Formazione di Daniel Schneider
| University of Washington | Masters Business Admin |
| St. Louis University | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Norvegia | 2 |
| Stati Uniti | 2 |
| Spagna | 2 |
Posizioni
| Chief Executive Officer | 2 |
| President | 1 |
| Masters Business Admin | 1 |
Settori
| Health Technology | 3 |
| Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| PHOTOCURE ASA | Health Technology |
| Aziende private | 1 |
|---|---|
Ablynx NV
 Ablynx NV BiotechnologyHealth Technology Ablynx NV operates as a clinical stage biopharmaceutical company, which engages in the development of proprietary therapeutic proteins under the Nanobodies brand. It includes haematology, inflammation, infectious disease, autoimmune disease, oncology and immune-oncology. The company was founded by Mark Vaeck in 2001 and is headquartered in Ghent, Belgium. | Health Technology |
- Borsa valori
- Insiders
- Daniel Schneider
- Esperienza
